Kawasaki Y - Search Results

1

Estimating the cost-effectiveness of screening for hepatitis C virus infection in Japan.

Nagai K, Ide K, Kawasaki Y, Tanaka-Mizuno S, Seto K, Iwane S, Eguchi Y, Kawakami K. Nagai K, et al. Among authors: kawasaki y. Hepatol Res. 2020 May;50(5):542-556. doi: 10.1111/hepr.13478. Epub 2020 Jan 22. Hepatol Res. 2020. PMID: 31899841

2

Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database.

Sato I, Shimbo T, Kawasaki Y, Mizokami M, Masaki N. Sato I, et al. Among authors: kawasaki y. Hepatol Res. 2015 Aug;45(8):829-386. doi: 10.1111/hepr.12419. Epub 2014 Oct 14. Hepatol Res. 2015. PMID: 25196978

3

Methods for estimating causal relationships of adverse events with dietary supplements.

Ide K, Yamada H, Kitagawa M, Kawasaki Y, Buno Y, Matsushita K, Kaji M, Fujimoto K, Waki M, Nakashima M, Umegaki K. Ide K, et al. Among authors: kawasaki y. BMJ Open. 2015 Nov 25;5(11):e009038. doi: 10.1136/bmjopen-2015-009038. BMJ Open. 2015. PMID: 26608636 Free PMC article.

4

Clinical Data Interchange Standards Consortium Standardization of Biobank Data: A Feasibility Study.

Sato I, Kawasaki Y, Ide K, Sakakibara I, Konomura K, Yamada H, Tanaka Y. Sato I, et al. Among authors: kawasaki y. Biopreserv Biobank. 2016 Feb;14(1):45-50. doi: 10.1089/bio.2015.0051. Epub 2015 Dec 21. Biopreserv Biobank. 2016. PMID: 26691957

5

Tomitaka S, Kawasaki Y, Ide K, Yamada H, Furukawa TA, Ono Y. Tomitaka S, et al. Among authors: kawasaki y. PeerJ. 2016 Jan 5;4:e1547. doi: 10.7717/peerj.1547. eCollection 2016. PeerJ. 2016. PMID: 26788427 Free PMC article.

6

Distribution of Total Depressive Symptoms Scores and Each Depressive Symptom Item in a Sample of Japanese Employees.

Tomitaka S, Kawasaki Y, Ide K, Yamada H, Miyake H, Furukawa TA. Tomitaka S, et al. Among authors: kawasaki y. PLoS One. 2016 Jan 26;11(1):e0147577. doi: 10.1371/journal.pone.0147577. eCollection 2016. PLoS One. 2016. PMID: 26812649 Free PMC article.

7

Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study.

Ide K, Kawasaki Y, Yamada H, Masaki N. Ide K, et al. Among authors: kawasaki y. Drug Des Devel Ther. 2016 Mar 22;10:1217-23. doi: 10.2147/DDDT.S102458. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27042013 Free PMC article.

8

Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study.

Ide K, Yamada H, Takuma N, Kawasaki Y, Harada S, Nakase J, Ukawa Y, Sagesaka YM. Ide K, et al. Among authors: kawasaki y. Nutr J. 2016 May 4;15(1):49. doi: 10.1186/s12937-016-0168-7. Nutr J. 2016. PMID: 27142448 Free PMC article. Clinical Trial.

9

Effect of gargling with tea and ingredients of tea on the prevention of influenza infection: a meta-analysis.

Ide K, Yamada H, Kawasaki Y. Ide K, et al. Among authors: kawasaki y. BMC Public Health. 2016 May 12;16:396. doi: 10.1186/s12889-016-3083-0. BMC Public Health. 2016. PMID: 27175786 Free PMC article.

10

Regional Differences in Hepatitis C Treatment with Peginterferon and Ribavirin in Japan in Both Genotype 1 and Genotype 2: A Retrospective Cohort Study.

Ide K, Kawasaki Y, Akutagawa M, Yamada H, Masaki N. Ide K, et al. Among authors: kawasaki y. Biol Pharm Bull. 2016 Sep 1;39(9):1538-43. doi: 10.1248/bpb.b16-00408. Epub 2016 Jul 7. Biol Pharm Bull. 2016. PMID: 27384444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,964 results

Search Page

Filters